United-Guardian (NASDAQ:UG) Posts Quarterly Earnings Results

United-Guardian (NASDAQ:UG) posted its quarterly earnings data on Monday. The company reported $0.20 earnings per share for the quarter, FiscalAI reports. United-Guardian had a return on equity of 22.24% and a net margin of 22.01%. The business had revenue of $3.49 million during the quarter.

United-Guardian Price Performance

Shares of United-Guardian stock opened at $8.85 on Tuesday. The company has a market cap of $40.62 million, a PE ratio of 16.39 and a beta of 0.99. The firm has a fifty day moving average price of $7.05 and a two-hundred day moving average price of $6.97. United-Guardian has a fifty-two week low of $5.58 and a fifty-two week high of $8.85.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of United-Guardian in a research report on Monday, October 19th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Institutional Investors Weigh In On United-Guardian

A number of institutional investors have recently added to or reduced their stakes in UG. Gamco Investors INC. ET AL raised its holdings in United-Guardian by 1.2% in the 1st quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock valued at $1,101,000 after acquiring an additional 1,888 shares in the last quarter. United Capital Financial Advisors LLC bought a new stake in shares of United-Guardian in the 2nd quarter worth approximately $143,000. Finally, BlackRock Inc. bought a new stake in shares of United-Guardian in the 2nd quarter worth approximately $105,000. 23.16% of the stock is owned by institutional investors and hedge funds.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.